Mental health treatment in the UK has come a long way, but for a significant number of people, it still falls short. Antidepressants that blunt everything rather than uplift. Therapy waiting lists stretching months. Sleep that never quite resets. For those stuck in that gap, a growing number are asking a different question: can a private cannabis clinic help?
The answer is not straightforward, but it is worth understanding. Medical cannabis has been legally prescribable in the UK since 2018. Despite that, it has been prescribed just five times within the NHS since legalization, meaning that for almost everyone who has found relief through it, the route has been a private clinic.
Key Takeaways:
- Medical cannabis has been legal in the UK since 2018 and can be prescribed for certain mental health conditions.
- Medical cannabis has been prescribed just five times on the NHS since legalisation; patients access it through specialist private clinics.
- The strongest evidence is around PTSD, anxiety disorders, and sleep disturbance linked to mental health conditions.
- Medical cannabis is not a first-line treatment; it is typically considered when other options have not worked well enough.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Medical cannabis treatment for mental health conditions requires a consultation with a qualified specialist clinician. If you are currently taking psychiatric medications, antidepressants, anxiolytics, or any other prescribed treatment, always inform your doctor or prescriber before starting any new treatment, as interactions may be relevant to your care. Whether medical cannabis is appropriate for you can only be determined by a GMC-registered specialist after a full review of your mental health history, previous treatments, and current circumstances. To find out whether you may be eligible, visit LeafEase.
Why the NHS Route Is Harder for Most Mental Health Patients
For someone already struggling with mental health issues, it can be very frustrating to go through the NHS route for medical cannabis. The reasons are structural rather than medical. Prescribing authority is technically available to any specialist physician on the General Medical Council register, but NHS trusts have created internal policies that make it almost impossible to prescribe in practice. Clinicians face significant administrative hurdles, and there is often no clear pathway for patients to follow.
Private clinics have filled that gap. They operate within the same legal framework; prescriptions must still be issued by a GMC-registered specialist, but without the institutional barriers that have made NHS access a near impossibility.
The Mental Health Conditions Where Medical Cannabis Is Being Prescribed
Post-Traumatic Stress Disorder (PTSD)
PTSD is one of the mental health conditions with the most developed evidence base for medical cannabis in the UK. Research published in Neuropsychopharmacology found that cannabis use was associated with a reduction in PTSD symptom severity, particularly around nightmares and hyperarousal. [1]
Consider someone who has been living with treatment-resistant PTSD following a traumatic incident. They have completed two courses of trauma-focused CBT and tried two different SSRIs, both of which provided limited relief. Nightmares and early-morning waking have persisted throughout. A specialist assessment would look at the full history of what has been tried, what effect it had, and whether cannabis-based medicine could address the specific symptoms that have not responded. Formulation and dosage would be tailored accordingly, with the aim of supporting sleep quality without producing daytime sedation.
Anxiety Disorders
Anxiety disorders cover a wide spectrum: generalised anxiety disorder, social anxiety, panic disorder, and health anxiety, among others. What they share is a pattern of excessive physiological and psychological threat response that significantly limits quality of life. A 2015 review in Neurotherapeutics examined cannabidiol (CBD) specifically and found preclinical and clinical evidence supporting its potential in reducing anxiety across multiple anxiety disorder subtypes, including generalised anxiety disorder and social anxiety disorder. [2]
Treatment-Resistant Depression
Depression that does not respond adequately to antidepressants is a significant clinical problem. Estimates suggest that around one-third of people with major depressive disorder do not achieve full remission on their first or second antidepressant. For this group, the search for effective treatment is often long and demoralising.
The evidence on cannabinoids and depression is still maturing, but there is growing interest in the relationship between the endocannabinoid system and mood regulation. Research published in the Journal of Affective Disorders found significant improvements in depression scores among patients prescribed cannabis-based medicinal products, with benefits sustained over a twenty-four-month observation period. [3]
Sleep Disorders Linked to Mental Health Conditions
Poor sleep and mental health are deeply connected. Disrupted sleep worsens anxiety and low mood; anxiety and low mood disrupt sleep further. Many patients presenting at private cannabis clinics have a primary mental health condition with insomnia as a compounding factor that standard treatment has not adequately addressed.
A systematic review and meta-analysis published in Sleep Medicine Reviews found that cannabinoid-based interventions, particularly those incorporating THC or CBN, were associated with significant improvements in subjective sleep quality compared to placebo. [4]
What Private Cannabis Clinics Offer That the NHS Currently Cannot
The difference is not merely one of access. Private cannabis clinics offer something structurally different: specialist time, continuity, and the ability to respond to an individual’s experience with their treatment over time.
At LeafEase, a patient’s full psychiatric history is reviewed before any prescription is issued. The formulation is not generic. THC-to-CBD ratios, dosing times, and delivery method are all considered in the context of that specific person’s daily life, existing medications, and symptom profile. Morning fog is one of the most common concerns patients raise before starting medical cannabis for mental health. The worry that medication will leave them sluggish, unfocused, or unable to function in the early part of the day is entirely understandable. At LeafEase, it is one of the first things your clinician addresses.
Consultations take place by video with GMC-registered specialist clinicians. Once a prescription is issued, medication is processed within 48 hours and delivered to your door in plain, discreet packaging with no indication of the contents on the outside. For patients who want continuity built in, the LeafEase Advantage subscription includes follow-up consultations with the same clinician who knows your history, ongoing monitoring, and free home delivery.
The assessment is thorough, the process is clear, and the clinical team understands the particular complexity of prescribing for mental health. You can check your eligibility in a few minutes to find out whether a consultation is the right next step.
Frequently Asked Questions
Can medical cannabis be prescribed for mental health conditions in the UK?
Yes. Since 2018, specialist physicians on the GMC register have been able to prescribe cannabis-based medicines for mental health conditions where other treatments have not been sufficiently effective. In practice, almost all prescribing happens through private clinics rather than the NHS, which has issued only five such prescriptions since legalisation.
Will medical cannabis affect my ability to function during the day?
This depends heavily on the formulation prescribed. CBD-dominant products and carefully titrated low-THC doses are used for patients where daytime clarity is a priority. A specialist will account for your daily routine, whether you drive, and your sensitivity to medication when recommending a starting point. If morning fog or daytime sedation becomes a concern, the formulation is adjusted.
Do I need a GP referral to access a private cannabis clinic?
No. You can book a consultation with LeafEase directly. It helps to have a summary of your mental health history and a record of treatments you have already tried, but a referral letter is not required to get started.
Is it safe to use medical cannabis alongside psychiatric medication?
Interactions are possible, particularly with certain antidepressants and anxiolytics. A prescribing specialist will review your full medication list before recommending any cannabis-based treatment. This is a standard part of the assessment, not an afterthought.
How long before I notice a difference?
Response times vary. Some patients notice improvements in sleep within the first one to two weeks. For mood and anxiety, it may take longer as the dose is titrated to the right level. Your clinician monitors progress and adjusts the formulation based on how you are responding.
References
[1] Hill, M.N., Campolongo, P., Yehuda, R. & Patel, S. (2018). Integrating endocannabinoid signalling and cannabinoids into the biology and treatment of posttraumatic stress disorder. Neuropsychopharmacology, 43(1), pp.80–102. Available at: https://pubmed.ncbi.nlm.nih.gov/28745306/ [Accessed: 1 June 2026].
[2] Blessing, E.M. et al. (2015). Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics, 12(4), pp.825–836. Available at: https://pubmed.ncbi.nlm.nih.gov/26341731/ [Accessed: 1 June 2026].
[3] Dalavaye, N., Erridge, S., Pillai, M., Bhoskar, U., Bapir, L., de Aquino, J.P. & Sodergren, M.H. (2026). UK Medical Cannabis Registry: A two-year case series of clinical outcomes in depression. Journal of Affective Disorders. Available at: https://www.sciencedirect.com/science/article/pii/S0165032725025728 [Accessed: 1 June 2026].
[4] da Silva, G.H.S., Barbosa, E.C., de Lima, F.R. et al. (2025). Effectiveness of cannabinoids on subjective sleep quality in people with and without insomnia or poor sleep: a systematic review and meta-analysis of randomised studies. Sleep Medicine Reviews. Available at: https://doi.org/10.1016/j.smrv.2025.102156 [Accessed: 1 June 2026].
